Regorafenib as Single Agent in Patients With Metastatic Colorectal Cancer (mCRC) With Any RAS or BRAF Mutation Previously Treated With FOLFOXIRI Plus Bevacizumab
PHASE2
The purpose of this study is to assess the efficacy of single-agent regoraf...
Status
Terminated
Location
Spanish Cooperative Group for Digestive Tumour Therapy (TTD)
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
PHASE3
The purpose of this study is to evaluate the efficacy of an investigational...
Status
Recruiting
Location
The University of Arizona Cancer Center-North Campus